2,3-Dibromo-1-[4-(2,3-dibromo-4,5-di­meth­oxy­benz­yl)-2,5-dimeth­oxy­benz­yl]-4,5-dimeth­oxy­benzene

Şahin, E.; Balaydın, H.T.; Göksu, S.; Menzek, A.

doi:10.1107/S1600536810043758

Volume 66
Part 11
Page o3029
November 2010

Received 8 October 2010
Accepted 26 October 2010
Online 31 October 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean (C-C) = 0.008 Å
R = 0.078
wR = 0.125
Data-to-parameter ratio = 16.8
Details

2,3-Dibromo-1-[4-(2,3-dibromo-4,5-dimethoxybenzyl)-2,5-dimethoxybenzyl]-4,5-dimethoxybenzene

Ertan Sahin,^a ^* Halis T. Balaydin,^b Süleyman Göksu ^a and Abdullah Menzek ^a

^aAtatürk University, Department of Chemistry, 25240 Erzurum, Turkey, and ^bArtvin Çoruh University, Education Faculty, 08100 Artvin, Turkey
Correspondence e-mail: ertan@atauni.edu.tr

The molecule of the title compound, C₂₆H₂₆Br₄O₆, is located around a crystallographic inversion center. The dihedral angle between the central benzene ring and the outer benzene ring is 89.26 (1)°.

Related literature

For information related to the synthesis of the title compound, see: Ford & Davidson (1993); Glombitza et al. (1985); Akbaba et al. (2010); Balaydin et al. (2009, 2010).

Experimental

Crystal data

C₂₆H₂₆Br₄O₆
M_r = 754.07
Monoclinic, P 2₁ /n
a = 11.193 (5) Å
b = 9.645 (4) Å
c = 13.212 (5) Å
= 107.125 (5)°
V = 1363.1 (10) Å³
Z = 2
Mo K radiation
= 5.94 mm^-1
T = 293 K
0.3 × 0.2 × 0.1 mm

Data collection

Rigaku R-AXIS RAPID-S diffractometer
Absorption correction: multi-scan (Blessing, 1995) T_min = 0.250, T_max = 0.552
27932 measured reflections
2793 independent reflections
2564 reflections with I > 2(I)
R_int = 0.080

Refinement

R[F² > 2(F²)] = 0.078
wR(F²) = 0.125
S = 1.45
2793 reflections
166 parameters
H-atom parameters constrained
_max = 0.29 e Å^-3
_min = -0.50 e Å^-3

Data collection: CrystalClear (Rigaku/MSC, 2005); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997); software used to prepare material for publication: WinGX (Farrugia, 1999).

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: GK2308 ).

Acknowledgements

The authors are indebted to Atatürk University and TÜBITAK (grant No. 107 T348) for financial support.

References

Akbaba, Y., Balaydin, H. T., Göksu, S., Sahin, E. & Menzek, A. (2010). Helv. Chim. Acta, 93, 1127-1135.
Balaydin, H. T., Akbaba, Y., Menzek, A., Sahin, E. & Göksu, S. (2009). Arkivoc, 14, 75-87.
Balaydin, H. T., Gülçin, I., Menzek, A., Göksu, S. & Sahin, E. (2010). J. Enzyme Inhib. Med. Chem. 25, 685-695.
Blessing, R. H. (1995). Acta Cryst. A51, 33-38.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
Ford, P. W. & Davidson, B. S. (1993). J. Org. Chem. 58, 4522-4523.
Glombitza, K. W., Sukopp, I. & Wiedenfeld, H. (1985). Planta Med. 51, 437-440.
Rigaku/MSC (2005). CrystalClear. Rigaku/MSC, The Woodlands, Texas, USA.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.

organic compounds